A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study): a …
Background Recent studies have reported improvement of outcomes (progression‐free
survival, overall survival, and prolongation of androgen deprivation treatment‐free survival) …
survival, overall survival, and prolongation of androgen deprivation treatment‐free survival) …
[HTML][HTML] Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Y Lievens, M Guckenberger, D Gomez, M Hoyer… - Radiotherapy and …, 2020 - Elsevier
Background Recognizing the rapidly increasing interest and evidence in using metastasis-
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
R Mazzola, BA Jereczek-Fossa, D Franceschini… - Radiation …, 2020 - Springer
Background During these last years, new agents have dramatically improved the survival of
the metastatic patients. Oligometastases represent a continuous field of interest in which the …
the metastatic patients. Oligometastases represent a continuous field of interest in which the …
Metastasis-directed therapy (SBRT) guided by PET-CT 18F-CHOLINE versus PET-CT 68Ga-PSMA in castration-sensitive oligorecurrent prostate cancer: a …
R Mazzola, G Francolini, L Triggiani, G Napoli… - Clinical genitourinary …, 2021 - Elsevier
Background The present analysis aims to compare the impact of 18F-fluorocholine (18 F-
choline) and gallium-68 prostate-specific membrane antigen (68 Ga-PSMA) positron …
choline) and gallium-68 prostate-specific membrane antigen (68 Ga-PSMA) positron …
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
L Triggiani, R Mazzola, SM Magrini, G Ingrosso… - World journal of …, 2019 - Springer
Purpose Herein, we report the clinical outcomes of a multicenter study evaluating the role of
SBRT in a cohort of patients affected by oligoprogressive castration-resistant prostate cancer …
SBRT in a cohort of patients affected by oligoprogressive castration-resistant prostate cancer …
[HTML][HTML] Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
Z Wang, L Wei, J Li, H Zhou, S Li, D Chen… - Translational Lung …, 2021 - ncbi.nlm.nih.gov
Background Immunotherapy has brought substantial benefit for patients with advanced non-
small cell lung cancer (NSCLC); however, resistance may occur, of which oligoprogression …
small cell lung cancer (NSCLC); however, resistance may occur, of which oligoprogression …
Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT
J Hörner-Rieber, D Bernhardt, O Blanck, M Duma… - Clinical lung cancer, 2019 - Elsevier
Introduction This multicenter study aims to analyze outcome as well as early versus late
patterns of recurrence following pulmonary stereotactic body radiotherapy (SBRT) for …
patterns of recurrence following pulmonary stereotactic body radiotherapy (SBRT) for …
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential …
P Bonomo, D Greto, I Desideri, M Loi, V Di Cataldo… - Oral oncology, 2019 - Elsevier
Objectives Oligometastatic head and neck squamous cell carcinoma (HNSCC) is a rare
entity with no evidence-based treatment recommendations available to support the use of …
entity with no evidence-based treatment recommendations available to support the use of …
[HTML][HTML] Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations
Simple Summary Gastric cancer (GC) represents a major global health challenge, ranking
as the second leading cause of cancer-related deaths. The high mortality rate is primarily …
as the second leading cause of cancer-related deaths. The high mortality rate is primarily …
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy
L Nicosia, F Cuccia, R Mazzola, F Ricchetti… - Strahlentherapie und …, 2020 - Springer
Purpose Stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy (SABR)
has been shown to increase survival rates in oligometastatic disease (OMD), but local …
has been shown to increase survival rates in oligometastatic disease (OMD), but local …